Literature DB >> 15288241

Development of gliomas: potential role of asymmetrical cell division of neural stem cells.

François Berger1, Emmanuel Gay, Laurent Pelletier, Philippe Tropel, Didier Wion.   

Abstract

Asymmetrical cell division is a mechanism that gives rise to two daughter cells with different proliferative and differentiative fates. It occurs mainly during development and in adult stem cells. Accumulating evidence suggests that tumour cells arise from the transformation of normal stem cells. Here, we propose that the asymmetrical mitosis potential of stem cells is associated with the generation of migrating tumour progenitors. Application of this speculative model to glioma proposes that the sites where tumour-initiating stem cells reside are indolent and distinct from the tumour mass, and implies that the tumour mass is continuously replenished with new migrating tumour cells from these clinically silent regions. This hypothesis offers explanations for our inability to cure glioblastoma and points to asymmetrical division as a new potential therapeutic target.

Entities:  

Mesh:

Year:  2004        PMID: 15288241     DOI: 10.1016/S1470-2045(04)01531-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  18 in total

1.  Cortical dysplasia: a possible substrate for brain tumors.

Authors:  Shiyong Liu; Chunqing Zhang; Haifeng Shu; Didier Wion; Hui Yang
Journal:  Future Oncol       Date:  2012-03       Impact factor: 3.404

2.  Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors.

Authors:  Sara Gil-Perotin; Mireya Marin-Husstege; Jiadong Li; Mario Soriano-Navarro; Frederique Zindy; Martine F Roussel; Jose-Manuel Garcia-Verdugo; Patricia Casaccia-Bonnefil
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

Review 3.  The interface between glial progenitors and gliomas.

Authors:  Peter Canoll; James E Goldman
Journal:  Acta Neuropathol       Date:  2008-09-11       Impact factor: 17.088

Review 4.  Novel treatment strategies for malignant gliomas using neural stem cells.

Authors:  Michael C Oh; Daniel A Lim
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

5.  Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cells.

Authors:  Iolanda D'Alimonte; Eleonora Nargi; Mariachiara Zuccarini; Paola Lanuti; Patrizia Di Iorio; Patricia Giuliani; Lucia Ricci-Vitiani; Roberto Pallini; Francesco Caciagli; Renata Ciccarelli
Journal:  Purinergic Signal       Date:  2015-05-15       Impact factor: 3.765

Review 6.  Biology, genetics and imaging of glial cell tumours.

Authors:  C Walker; A Baborie; D Crooks; S Wilkins; M D Jenkinson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

7.  Inhibition of heme oxygenase-1 enhances anti-cancer effects of arsenic trioxide on glioma cells.

Authors:  Yaohua Liu; Yuan Liang; Tianhu Zheng; Guang Yang; Xu Zhang; Zhe Sun; Changbin Shi; Shiguang Zhao
Journal:  J Neurooncol       Date:  2011-02-17       Impact factor: 4.130

Review 8.  Brain cancer stem cells.

Authors:  Sara G M Piccirillo; Elena Binda; Roberta Fiocco; Angelo L Vescovi; Khalid Shah
Journal:  J Mol Med (Berl)       Date:  2009-09-29       Impact factor: 4.599

Review 9.  Cancer stem cells and brain tumors.

Authors:  A Pérez Castillo; D Aguilar-Morante; J A Morales-García; J Dorado
Journal:  Clin Transl Oncol       Date:  2008-05       Impact factor: 3.405

10.  Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype.

Authors:  Daniel A Lim; Soonmee Cha; Mary C Mayo; Mei-Hsiu Chen; Evren Keles; Scott VandenBerg; Mitchel S Berger
Journal:  Neuro Oncol       Date:  2007-07-10       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.